Brazil, our production of value added and new products
at this facility, the market demand and pricing for rice bran oil and
deoiled bran and the impact of this facility on our revenue and profit,,
all of which statements are subject to market risks, and the possibility
that NutraCea will not be able to utilize available capacity as expected,
complete the plant modifications and expansions on a timely basis, operate
the plant efficiently, or obtain sufficient customer demand to utilize
expected production and realize profit from the plant. These statements are
made based upon current expectations and actual results may differ from
those projected due to a number of risks and uncertainties. The Company
does not undertake to update forward-looking statements in this news
release to reflect actual results, changes in assumptions or changes in
other factors affecting such forward- looking information. Assumptions and
other information that could cause results to differ from those set forth
in the forward-looking information can be found in the Company's filings
with the Securities and Exchange Commission, including the company's most
recent periodic report.
'/>"/>SOURCE NutraCea Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Consumers Offer to Pay More to Satisfy Health Demands2.
Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications3.
Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community4.
DuPont Focused on Meeting Global Demands for Greater Safety & Protection5.
BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand6.
Dynamic Energy Systems Goes Online and On-Demand7.
ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products8.
The Physical Therapy Profession Remains in High Demand9.
Caregivers Demand County Honor Their Contract10.
US-Based Bollywood On-Demand Service to Sponsor Faces of India YouthAIDS Gala on November 2nd11.
ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.